BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29321129)

  • 1. Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.
    Basu D; Hu Y; Huggins LA; Mullick AE; Graham MJ; Wietecha T; Barnhart S; Mogul A; Pfeiffer K; Zirlik A; Fisher EA; Bornfeldt KE; Willecke F; Goldberg IJ
    Circ Res; 2018 Feb; 122(4):560-567. PubMed ID: 29321129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).
    Teupser D; Persky AD; Breslow JL
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1907-13. PubMed ID: 12907460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
    Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
    J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
    Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression.
    Bartels ED; Christoffersen C; Lindholm MW; Nielsen LB
    Circ Res; 2015 Nov; 117(11):933-42. PubMed ID: 26358193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
    Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
    PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
    Lian J; Quiroga AD; Li L; Lehner R
    Circ Res; 2012 Sep; 111(8):982-90. PubMed ID: 22872154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis.
    Gomes D; Wang S; Goodspeed L; Turk KE; Wietecha T; Liu Y; Bornfeldt KE; O'Brien KD; Chait A; den Hartigh LJ
    J Lipid Res; 2022 Mar; 63(3):100174. PubMed ID: 35101425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
    Davis BT; Wang XJ; Rohret JA; Struzynski JT; Merricks EP; Bellinger DA; Rohret FA; Nichols TC; Rogers CS
    PLoS One; 2014; 9(4):e93457. PubMed ID: 24691380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    Lede V; Franke C; Meusel A; Teupser D; Ricken A; Thiery J; Schiller J; Huster D; Schöneberg T; Schulz A
    PLoS One; 2016; 11(12):e0167888. PubMed ID: 28030540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
    Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
    J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease.
    Zhou C; Pridgen B; King N; Xu J; Breslow JL
    J Lipid Res; 2011 Aug; 52(8):1483-93. PubMed ID: 21606463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice.
    Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM
    J Lipid Res; 2011 May; 52(5):885-96. PubMed ID: 21343632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.